Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.64
-0.03 (-0.53%)
Aug 7, 2025, 4:00 PM - Market closed
Blueprint Medicines Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$15.63
Upside
+177.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $26 → $15 | Buy | Maintains | $26 → $15 | +165.96% | May 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +254.61% | Apr 21, 2025 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 28, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +254.61% | Dec 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +254.61% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7.5 | Hold | Reiterates | $7.5 | +32.98% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5.5 → $7.5 | Hold | Maintains | $5.5 → $7.5 | +32.98% | Nov 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +201.42% | Oct 31, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $19 → $26 | Buy | Reiterates | $19 → $26 | +360.99% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +254.61% | Sep 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +165.96% | Sep 3, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $19 | Buy | Reiterates | $19 | +236.88% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | -2.48% | May 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +165.96% | Apr 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | -2.48% | Apr 30, 2024 |
| UBS | UBS | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +219.15% | Mar 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.